NCT06813144

Brief Summary

It has been observed that there are negative effects on respiratory muscle strength following lobectomy. This has led to the necessity of respiratory muscle training to mitigate these adverse effects. Most studies conducted so far focus on the late postoperative period, and there are only a few studies evaluating the effectiveness of early postoperative inspiratory muscle training (IMT). It is believed that this method could be useful for facilitating patient follow-up and increasing patient motivation through visual feedback.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
45

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2025

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 22, 2025

Completed
15 days until next milestone

First Posted

Study publicly available on registry

February 6, 2025

Completed
23 days until next milestone

Study Start

First participant enrolled

March 1, 2025

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2026

Completed
Last Updated

February 6, 2025

Status Verified

January 1, 2025

Enrollment Period

9 months

First QC Date

January 22, 2025

Last Update Submit

February 3, 2025

Conditions

Keywords

lung cancervatsinspiratory muscle training

Outcome Measures

Primary Outcomes (2)

  • Inspiratory muscle strength

    Respiratory muscle strength will measure by measuring mouth pressure and using maximal inspiratory pressure (MIP) values.

    Measurements will be performed before surgery (the day before surgery), at discharge and during the follow-up period after surgery (10-15 days after discharge).

  • Expiratory muscle strength

    Respiratory muscle strength will measure by measuring mouth pressure and using maximal expiratory pressure (MEP) values.

    Measurements will be performed before surgery (the day before surgery), at discharge and during the follow-up period after surgery (10-15 days after discharge).

Secondary Outcomes (6)

  • Functional exercise capacity

    Evaluations will be made before surgery (the day before surgery) and during the follow-up period (10-15 days after discharge).

  • Postoperative Pulmonary Complications

    Postoperative first-fifth days.

  • Exercise Motivation

    The evaluation will be made during the control period (10-15 days after discharge).

  • Dyspnea Level

    An evaluation will be made in the preoperative (the day before surgery) and control period (10-15 days after discharge).

  • Quality of Life

    The evaluation will be made during the preoerative (the day before surgery) and control (10-15 days after discharge) period.

  • +1 more secondary outcomes

Study Arms (3)

Classic IMT

ACTIVE COMPARATOR

Individuals who are between the ages of 18-65 and lung cancer patient, underwent lobectomy with video-assisted thoracic surgery. The group will receive standard postoperative physiotherapy and rehabilitation as well as classical inspiratory muscle strength training with the noninvasive Powerbreath Medic Plus device (POWERbreathe International Ltd., Warwickshire, England). Training will start with 40 percent of the initial MIP level and progress will be planned according to Modified Borg between 3-4. It will be repeated twice a day for 3 times 10 minutes. Training will start on the 1st postoperative day after the participants are transferred to the ward and they will be asked to continue at home. The progress plan will be adjusted by talking to the patient on the phone every 2 days after discharge.

Other: inspiratory muscle exercise

IMT with mobile application

EXPERIMENTAL

Individuals who are between the ages of 18-65 and lung cancer patient, underwent lobectomy with video-assisted thoracic surgery. The group will receive standard postoperative physiotherapy and rehabilitation as well as inspiratory muscle training with the smart adapter support (POWERbreathe International Ltd., Warwickshire, England). Training will start with 40 percent of the initial MIP level and progress will be planned according to Modified Borg between 3-4. It will be repeated twice a day for 3 times 10 minutes. Training will start on the 1st postoperative day after the participants are transferred to the ward and they will be asked to continue at home. The progress plan will be adjusted by talking to the patient on the phone every 2 days after discharge.

Other: inspiratory muscle exercise

control group

NO INTERVENTION

Individuals who are between the ages of 18-65 and lung cancer patient, underwent lobectomy with video-assisted thoracic surgery. This group will receive only standard physiotherapy and rehabilitation: respiratory exercises (thoracic expansion exercises, diaphragmatic breathing, incentive spirometry), mobilization and cough/huffing training. Participants will be advised to continue these exercises regularly at home.

Interventions

Inspiratory muscle training will be given with or without smart adaptor.

Classic IMTIMT with mobile application

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Volunteering to participate in the study,
  • Being clinically stable,
  • Being a lung cancer patient with a planned lobectomy with VATS,
  • Being between the ages of 18-65,
  • Being able to cooperate with the tests to be performed.

You may not qualify if:

  • Having any orthopedic or neurological problem that prevents walking,
  • Having undergone any surgery related to the thoracic wall,
  • Having diseases that will affect respiratory parameters such as severe heart failure, severe chronic obstructive pulmonary disease (COPD).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hacettepe University

Ankara, 06100, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Lung NeoplasmsCarcinoma, Non-Small-Cell Lung

Condition Hierarchy (Ancestors)

Respiratory Tract NeoplasmsThoracic NeoplasmsNeoplasms by SiteNeoplasmsLung DiseasesRespiratory Tract DiseasesCarcinoma, BronchogenicBronchial Neoplasms

Study Officials

  • Ebru Calik Kutukcu, Professorr

    Hacettepe University

    STUDY DIRECTOR

Central Study Contacts

Ebru Calik Kutukcu, Professor

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
double blind (participant and statistician)
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PHD student, physiotherapist

Study Record Dates

First Submitted

January 22, 2025

First Posted

February 6, 2025

Study Start

March 1, 2025

Primary Completion

December 1, 2025

Study Completion

February 1, 2026

Last Updated

February 6, 2025

Record last verified: 2025-01

Locations